Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-009990
Filing Date
2024-02-01
Accepted
2024-02-01 21:58:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3968
  Complete submission text file 0000950170-24-009990.txt   5642
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36257 | Film No.: 24588651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130
Business Address
Heerma Peter (Reporting) CIK: 0001789617 (see all company filings)

Type: 144